Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -5.048% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) CCCN(CC(=O)Nc1ccccc1C)C(=O)COc1c(C)cccc1C
b.) CCOC(=O)C1=C(COC(=O)c2ccc3ccccc3c2O)NC(=O)NC1C
c.) c1ccc(N2OCC3Cn4c(nc5ccccc54)C32)cc1
d.) COc1cc(C)ccc1OCC(=O)Nc1ccc2c(c1)OCO2
Answer: c. c1ccc(N2OCC3Cn4c(nc5ccccc54)C32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc(N2OCC3Cn4c(nc5ccccc54)C32)cc1
c1ccc(N2OCC3Cn4c(nc5ccccc54)C32)cc1
11-phenyl-12-oxa-1,8,11-triazatetracyclo[7.6.0.02,7.010,14]pentadeca-2,4,6,8-tetraene